Eosinophilic esophagitis drives tissue fibroblast regenerative programs toward pathologic dysfunction. Jumabay M, Abud EM, Okamoto K, Dutta P, et al. J Allergy Clin Immunol 2025;155:1333-1345.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Jumabay M, Abud EM, Okamoto K, Dutta P, et al. Eosinophilic esophagitis drives tissue fibroblast regenerative programs toward pathologic dysfunction. J Allergy Clin Immunol 2025;155:1333-1345.
PMID: 39617290